We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Partnership Developed to Create Tools to Speed Contaminant Detection

By LabMedica International staff writers
Posted on 05 Oct 2009
Millipore (Billerica, MA, USA) and the newly created Roka Bioscience reported they are jointly developing molecular assays and portable instruments for biopharmaceutical production. More...
Roka is a spinoff of Gen-Probe (San Diego, CA, USA).

The joint effort is focused on accelerating the detection of microbial contamination so biopharma manufacturers can take corrective actions earlier in the production process, limiting contamination impact. The earlier intervention is expected to reduce downstream processing risks and optimize product yields.

The work is based on a Millipore and Gen-Probe partnership dating to 2005. It led to the MilliProbe system, which combines Millipore sample prep methodologies with Gen-Probe nucleic acid technologies for speed and sensitivity in one microbial screening application. MilliProbe utilizes real-time transcription-mediated amplification technology to detect contaminants.

The partners have one assay on the market for Pseudomonas aeruginosa and are developing a second assay for Mycoplasma.

Related Links:

Millipore
Gen-Probe



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Automated Urinalysis Solution
UN-9000
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.